{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T04:27:51Z","timestamp":1794112071157,"version":"4.8.0"},"reference-count":325,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Inflammation has been widely recognized as one of the major pathophysiological drivers of the development of atrial fibrillation (AF), which works in tandem with other risk factors of AF including obesity, diabetes, hypertension, and heart failure (HF). Our current understanding of the role of inflammation in the natural history of AF remains elusive; however, several key players, including the NLRP3 (NLR family pyrin domain containing 3) inflammasome, have been acknowledged to be heavily influential on chronic inflammation in the atrial myocardium, which leads to fibrosis and eventual degradation of its electrical function. Nevertheless, our current methods of pharmacological modalities with reported immunomodulatory properties, including well-established classes of drugs e.g., drugs targeting the renin\u2013angiotensin\u2013aldosterone system (RAAS), statins, and vitamin D, have proven effective in reducing the overall risk of developing AF, the onset of postoperative atrial fibrillation (POAF), and reducing overall mortality among patients with AF. This might bring hope for further progress in developing new treatment modalities targeting cellular checkpoints of the NLRP3 inflammasome pathway, or revisiting other well-known anti-inflammatory drugs e.g., colchicine, vitamin C, nonsteroidal anti-inflammatory drugs (NSAIDs), glucocorticosteroids, and antimalarial drugs. In our review, we aim to find relevant upstream anti-inflammatory treatment methods for the management of AF and present the most current real-world evidence of their clinical utility.<\/jats:p>","DOI":"10.3390\/jcm14030882","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T03:26:10Z","timestamp":1738121170000},"page":"882","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Exploring Anti-Inflammatory Treatment as Upstream Therapy in the Management of Atrial Fibrillation"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0496-293X","authenticated-orcid":false,"given":"Edward","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Interventional Cardiology and Heart Rhythm Diseases, Teaching Hospital No.2 of Medical University of Lodz, Faculty of Medicine, Medical University of Lodz, Zermoskiego 114, 91-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6514-656X","authenticated-orcid":false,"given":"Izabela","family":"Warcho\u0142","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology and Heart Rhythm Diseases, Teaching Hospital No.2 of Medical University of Lodz, Faculty of Medicine, Medical University of Lodz, Zermoskiego 114, 91-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2012-5882","authenticated-orcid":false,"given":"Maja","family":"Mejza","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology and Heart Rhythm Diseases, Teaching Hospital No.2 of Medical University of Lodz, Faculty of Medicine, Medical University of Lodz, Zermoskiego 114, 91-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mo\u017cd\u017can","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology and Heart Rhythm Diseases, Teaching Hospital No.2 of Medical University of Lodz, Faculty of Medicine, Medical University of Lodz, Zermoskiego 114, 91-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Strzemi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology and Heart Rhythm Diseases, Teaching Hospital No.2 of Medical University of Lodz, Faculty of Medicine, Medical University of Lodz, Zermoskiego 114, 91-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bajer","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology and Heart Rhythm Diseases, Teaching Hospital No.2 of Medical University of Lodz, Faculty of Medicine, Medical University of Lodz, Zermoskiego 114, 91-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Madura","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology and Heart Rhythm Diseases, Teaching Hospital No.2 of Medical University of Lodz, Faculty of Medicine, Medical University of Lodz, Zermoskiego 114, 91-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliusz","family":"\u017bak","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology and Heart Rhythm Diseases, Teaching Hospital No.2 of Medical University of Lodz, Faculty of Medicine, Medical University of Lodz, Zermoskiego 114, 91-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Plewka","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology and Heart Rhythm Diseases, Teaching Hospital No.2 of Medical University of Lodz, Faculty of Medicine, Medical University of Lodz, Zermoskiego 114, 91-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Rienstra","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart Disease and Stroke Statistics\u20142019 Update: A Report From the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/clc.22667","article-title":"Silent atrial fibrillation: Epidemiology, diagnosis, and clinical impact","volume":"40","author":"Dilaveris","year":"2017","journal-title":"Clin. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.hroo.2020.06.003","article-title":"Atrioventricular junctional ablation: The good, the bad, the better","volume":"1","author":"Scherlag","year":"2020","journal-title":"Heart Rhythm. O2"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1093\/eurheartj\/ehad615","article-title":"Acquired risk factors and incident atrial fibrillation according to age and genetic predisposition","volume":"44","author":"Wang","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Krogh-Madsen, T., Abbott, G.W., and Christini, D.J. (2012). Effects of Electrical and Structural Remodeling on Atrial Fibrillation Maintenance: A Simulation Study. PLoS Comput. Biol., 8.","DOI":"10.1371\/journal.pcbi.1002390"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ihara, K., and Sasano, T. (2022). Role of Inflammation in the Pathogenesis of Atrial Fibrillation. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.862164"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41569-022-00759-w","article-title":"Inflammatory signalling in atrial cardiomyocytes: A novel unifying principle in atrial fibrillation pathophysiology","volume":"20","author":"Dobrev","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kelley, N., Jeltema, D., Duan, Y., and He, Y. (2019). The NLRP3 inflammasome: An overview of mechanisms of activation and regulation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133328"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ozkan, E., Elcik, D., Barutcu, S., Kelesoglu, S., Alp, M.E., Ozan, R., Capar, G., Turkmen, O., Cinier, G., and Polat, V. (2023). Inflammatory Markers as Predictors of Atrial Fibrillation Recurrence: Exploring the C-Reactive Protein to Albumin Ratio in Cryoablation Patients. J. Clin. Med., 12.","DOI":"10.3390\/jcm12196313"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2796.2010.02310.x","article-title":"Psoriasis is associated with clinically significant cardiovascular risk: A Danish nationwide cohort study","volume":"270","author":"Ahlehoff","year":"2011","journal-title":"J. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/joa3.12473","article-title":"Role of inflammation in atrial fibrillation: A comprehensive review of current knowledge","volume":"37","author":"Nso","year":"2021","journal-title":"J. Arrhythm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccep.2020.11.002","article-title":"Implications of Inflammation and Fibrosis in Atrial Fibrillation Pathophysiology","volume":"13","author":"Harada","year":"2021","journal-title":"Card. Electrophysiol. Clin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation","volume":"12","author":"Hu","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Turner, N.A., and Blythe, N.M. (2019). Cardiac fibroblast p38 MAPK: A critical regulator of myocardial remodeling. J. Cardiovasc. Dev. Dis., 6.","DOI":"10.3390\/jcdd6030027"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/14017430802651803","article-title":"Activated nuclear factor-\u03baB and increased tumor necrosis factor-\u03b1 in atrial tissue of atrial fibrillation","volume":"43","author":"Qu","year":"2009","journal-title":"Scand. Cardiovasc. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1161\/CIRCULATIONAHA.114.011204","article-title":"Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: Insights from the Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial","volume":"130","author":"Wallentin","year":"2014","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cvr\/cvt074","article-title":"Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-\u03b21","volume":"99","author":"Rahmutula","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/pace.14944","article-title":"Ion channel dysfunction and fibrosis in atrial fibrillation: Two sides of the same coin","volume":"47","author":"Arabia","year":"2024","journal-title":"PACE Pacing Clin. Electrophysiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"104820","DOI":"10.1016\/j.yexmp.2022.104820","article-title":"ST2 and the alteration of cobalt, sodium, potassium and calcium concentration in acute inflammation","volume":"128","author":"Stankovic","year":"2022","journal-title":"Exp. Mol. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1161\/01.CIR.94.11.2968","article-title":"Electrical Remodeling in Atrial Fibrillation","volume":"94","author":"Goette","year":"1996","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"C372","DOI":"10.1152\/ajpcell.00186.2007","article-title":"NF-\u03baB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II","volume":"294","author":"Shang","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lfs.2016.04.013","article-title":"Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis","volume":"153","author":"Bai","year":"2016","journal-title":"Life Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","article-title":"Atrial Fibrosis: Mechanisms and Clinical Relevance in Atrial Fibrillation","volume":"51","author":"Burstein","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e011006","DOI":"10.1161\/JAHA.118.011006","article-title":"Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6\u2013Mediated Changes in Connexin Expression","volume":"8","author":"Lazzerini","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The Inflammasome","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: Molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41422-020-0295-8","article-title":"Toward targeting inflammasomes: Insights into their regulation and activation","volume":"30","author":"Christgen","year":"2020","journal-title":"Cell Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","article-title":"Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation","volume":"138","author":"Yao","year":"2018","journal-title":"Circulation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/europace\/euq321","article-title":"Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease","volume":"12","author":"Luan","year":"2010","journal-title":"Europace"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Cabaro, S., Conte, M., Moschetta, D., Petraglia, L., Valerio, V., Romano, S., Di Tolla, M.F., Campana, P., Comentale, G., and Pilato, E. (2022). Epicardial Adipose Tissue-Derived IL-1\u03b2 Triggers Postoperative Atrial Fibrillation. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.893729"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/bmj.333.7570.695","article-title":"ABC of obesity: Assessment of obesity and its clinical implications","volume":"333","author":"Han","year":"2006","journal-title":"Br. Med. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacep.2015.04.004","article-title":"Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: A meta-analysis of 626,603 individuals in 51 studies","volume":"1","author":"Wong","year":"2015","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","article-title":"Obesity and the risk of new-onset atrial fibrillation","volume":"292","author":"Wang","year":"2004","journal-title":"JAMA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/europace\/eus422","article-title":"Obesity is a risk factor for atrial fibrillation among fertile young women: A nationwide cohort study","volume":"15","author":"Karasoy","year":"2013","journal-title":"Europace"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: A randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: A long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: The ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1079\/PNS2001110","article-title":"Pro-inflammatory cytokines and adipose tissue","volume":"60","author":"Coppack","year":"2001","journal-title":"Proc. Nutr. Soc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.pharmtox.45.120403.095843","article-title":"Fat cells: Afferent and efferent messages define new approaches to treat obesity","volume":"45","author":"Lafontan","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00011-009-0060-4","article-title":"The major inflammatory mediator interleukin-6 and obesity","volume":"58","author":"Eder","year":"2009","journal-title":"Inflamm. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbrc.2005.09.068","article-title":"The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNF\u03b1 in human adipocytes","volume":"337","author":"Wood","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.2147\/DMSO.S321311","article-title":"Effect of leptin on chronic inflammatory disorders: Insights to therapeutic target to prevent further cardiovascular complication","volume":"14","author":"Dessie","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm.1964","article-title":"CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity","volume":"15","author":"Nishimura","year":"2009","journal-title":"Nat. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e032277","DOI":"10.1161\/JAHA.123.032277","article-title":"Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options","volume":"13","author":"Sha","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.hrthm.2011.03.038","article-title":"Smoking and incidence of atrial fibrillation: Results from the Atherosclerosis Risk in Communities (ARIC) study","volume":"8","author":"Chamberlain","year":"2011","journal-title":"Heart Rhythm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"132342","DOI":"10.1016\/j.ijcard.2024.132342","article-title":"Clinical impact of smoking on atrial fibrillation recurrence after pulmonary vein isolation","volume":"413","author":"Giomi","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e2217132","DOI":"10.1001\/jamanetworkopen.2022.17132","article-title":"Risk of Dementia after Smoking Cessation in Patients with Newly Diagnosed Atrial Fibrillation","volume":"5","author":"Lee","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Lee, S.R., Choi, E.K., Jung, J.H., Han, K.D., Oh, S., and Lip, G.Y.H. (2021). Smoking cessation after diagnosis of new-onset atrial fibrillation and the risk of stroke and death. J. Clin. Med., 10.","DOI":"10.3390\/jcm10112238"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e23826","DOI":"10.1096\/fj.202400858R","article-title":"Cardiac diastolic dysfunction by cigarette smoking is associated with mitochondrial integrity in the heart","volume":"38","author":"Slotabec","year":"2024","journal-title":"FASEB J."},{"key":"ref_55","first-page":"89","article-title":"Acute effects of smoking on QT dispersion in healthy males","volume":"10","author":"Akbarzadeh","year":"2014","journal-title":"ARYA Atheroscler."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"106820","DOI":"10.1016\/j.intimp.2020.106820","article-title":"Activation of NLRP3 inflammasome assembly is associated with smoking status of patients with coronary artery disease","volume":"87","author":"Mehta","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-017-0257-3","article-title":"Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis","volume":"9","author":"Wu","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cjca.2022.12.010","article-title":"Alcohol Consumption and Atrial Arrhythmia Recurrence After Atrial Fibrillation Ablation: A Systematic Review and Meta-analysis","volume":"39","author":"Grindal","year":"2023","journal-title":"Can. J. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/europace\/euy117","article-title":"PREVEntion and regReSsive effect of weight-loss and risk factor modification on Atrial Fibrillation: The REVERSE-AF study","volume":"20","author":"Middeldorp","year":"2018","journal-title":"Europace"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/eurjpc\/zwad270","article-title":"Changes in alcohol consumption habits and risk of atrial fibrillation: A nationwide population-based study","volume":"31","author":"Lee","year":"2024","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_61","first-page":"1","article-title":"Alcohol and the risk of all-cause death, atrial fibrillation, ventricular arrhythmia, and sudden cardiac arrest","volume":"14","author":"Kim","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Jiang, H., Mei, X., Jiang, Y., Yao, J., Shen, J., Chen, T., and Zhou, Y. (2022). Alcohol consumption and atrial fibrillation risk: An updated dose-response meta-analysis of over 10 million participants. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.979982"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.1600406","article-title":"Ethanol and Other Short-Chain Alcohols Inhibit NLRP3 Inflammasome Activation through Protein Tyrosine Phosphatase Stimulation","volume":"197","author":"Hoyt","year":"2016","journal-title":"J. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.surg.2017.04.014","article-title":"Alcohol attenuates myocardial ischemic injury","volume":"162","author":"Scrimgeour","year":"2017","journal-title":"Surgery"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"155629","DOI":"10.1016\/j.cyto.2021.155629","article-title":"The effect of moderate wine consumption on cytokine secretion by peripheral blood mononuclear cells: A randomized clinical study in coronary heart disease patients","volume":"146","author":"Fragopoulou","year":"2021","journal-title":"Cytokine"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.31083\/j.rcm2403073","article-title":"Alcohol and Atrial Fibrillation","volume":"24","author":"Surma","year":"2023","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.jacc.2016.08.074","article-title":"Alcohol and Atrial Fibrillation: A Sobering Review","volume":"68","author":"Voskoboinik","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s12192-019-01015-w","article-title":"Ethanol exposure in prenatal and early postnatal induced cardiac injury in rats: Involvement of oxidative stress, Hsp70, ERK 1\/2, JNK, and apoptosis in a 3-month follow-up study","volume":"24","author":"Shirpoor","year":"2019","journal-title":"Cell Stress Chaperones"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10840-022-01233-w","article-title":"Incidence and risk factors of atrial fibrillation and atrial arrhythmias in people living with HIV: A systematic review and meta-analysis","volume":"65","author":"Park","year":"2022","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"E98","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, Prevention, and Management of Cardiovascular Disease in People Living with HIV: A Scientific Statement from the American Heart Association","volume":"140","author":"Feinstein","year":"2019","journal-title":"Circulation"},{"key":"ref_71","first-page":"1","article-title":"Cytokine trajectory over time in men and women with HIV on long-term ART","volume":"39","author":"Vanpouille","year":"2024","journal-title":"AIDS"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/QAD.0000000000003180","article-title":"Risk factors for atrial fibrillation in a multicenter United States clinical cohort of people with HIV infection","volume":"36","author":"Nance","year":"2022","journal-title":"AIDS"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.cjca.2018.12.020","article-title":"Getting to the Heart of the Matter: A Review of Drug Interactions Between HIV Antiretrovirals and Cardiology Medications","volume":"35","author":"Nhean","year":"2019","journal-title":"Can. J. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1111\/jce.16076","article-title":"Catheter ablation approach and outcome in HIV+ patients with recurrent atrial fibrillation","volume":"34","author":"Pierucci","year":"2023","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e012914","DOI":"10.1161\/JAHA.119.012914","article-title":"Risk of New-Onset Atrial Fibrillation Among Asian Chronic Hepatitis C Virus Carriers: A Nationwide Population-Based Cohort Study","volume":"8","author":"Yang","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jjcc.2019.03.009","article-title":"Risk of cardiac arrhythmias in patients with chronic hepatitis B and C infections\u2014A 13-year nationwide population-based study","volume":"74","author":"Wu","year":"2019","journal-title":"J. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e12705","DOI":"10.1111\/anec.12705","article-title":"Associations between QT interval subcomponents, HIV serostatus, and inflammation","volume":"25","author":"Wu","year":"2020","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e004091","DOI":"10.1161\/CIRCIMAGING.115.004091","article-title":"Cardiac Magnetic Resonance Reveals Signs of Subclinical Myocardial Inflammation in Asymptomatic HIV-Infected Patients","volume":"9","author":"Luetkens","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.4254\/wjh.v7.i19.2214","article-title":"Assessing cardiovascular risk in hepatitis C: An unmet need","volume":"7","author":"Ampuero","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/JCMA.0000000000000517","article-title":"Persistent liver inflammation in chronic hepatitis C patients with advanced fibrosis after direct-acting antivirals induced sustained virological response","volume":"84","author":"Hsieh","year":"2021","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Choi, J., Lee, S.R., Choi, E.K., Ahn, H.J., Kwon, S., Park, S.H., Lee, H., Chung, J., Han, M., and Lee, S.W. (2022). Non-alcoholic Fatty Liver Disease and the Risk of Incident Atrial Fibrillation in Young Adults: A Nationwide Population-Based Cohort Study. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.832023"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2014.03.048","article-title":"Alcohol consumption and risk of atrial fibrillation: A prospective study and dose-response meta-analysis","volume":"64","author":"Larsson","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_83","first-page":"e1142","article-title":"Link Between Non-Alcoholic Fatty Liver Disease and Atrial Fibrillation: A Systematic Review and Meta-Analysis","volume":"9","author":"Minhas","year":"2017","journal-title":"Cureus"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/europace\/euac244","article-title":"Autoimmune diseases and new-onset atrial fibrillation: A UK Biobank study","volume":"25","author":"Tilly","year":"2023","journal-title":"Europace"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.12998\/wjcc.v9.i14.3252","article-title":"Burden of atrial fibrillation in patients with rheumatic diseases","volume":"9","author":"Khan","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e1257","DOI":"10.1136\/bmj.e1257","article-title":"Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study","volume":"344","author":"Lindhardsen","year":"2012","journal-title":"BMJ"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.hlc.2015.08.003","article-title":"Atrial Electromechanical Properties in Coeliac Disease","volume":"25","author":"Efe","year":"2016","journal-title":"Heart Lung Circ."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/europace\/eut312","article-title":"Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: A nationwide study","volume":"16","author":"Kristensen","year":"2014","journal-title":"Europace"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S2213-8587(19)30059-2","article-title":"Primary therapy of Graves\u2019 disease and cardiovascular morbidity and mortality: A linked-record cohort study","volume":"7","author":"Okosieme","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Berta, E., Lengyel, I., Halmi, S., Zr\u00ednyi, M., Erdei, A., Harangi, M., P\u00e1ll, D., Nagy, E.V., and Bodor, M. (2019). Hypertension in thyroid disorders. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00482"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1210\/clinem\/dgaa239","article-title":"Thyroid Function Affects the Risk of Stroke via Atrial Fibrillation: A Mendelian Randomization Study","volume":"105","author":"Marouli","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5114\/jhi.2020.97044","article-title":"Level of selected pro-inflammatory markers in middle-aged women with Hashimoto\u2019s disease","volume":"6","author":"Szczepanik","year":"2020","journal-title":"J. Health Inequalities"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Siddiq, A., Naveed, A.K., Ghaffar, N., Aamir, M., and Ahmed, N. (2023). Association of Pro-Inflammatory Cytokines with Vitamin D in Hashimoto\u2019s Thyroid Autoimmune Disease. Medicina, 59.","DOI":"10.3390\/medicina59050853"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2021.654473","article-title":"Cytokines as Targets of Novel Therapies for Graves\u2019 Ophthalmopathy","volume":"12","author":"Fallahi","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Heidari, Z., Salimi, S., Rokni, M., Rezaei, M., Khalafi, N., Shahroudi, M.J., Dehghan, A., and Saravani, M. (2021). Association of IL-1 \u03b2, NLRP3, and COX-2 Gene Polymorphisms with Autoimmune Thyroid Disease Risk and Clinical Features in the Iranian Population. BioMed Res. Int., 2021.","DOI":"10.1155\/2021\/7729238"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Hajje, G., Saliba, Y., Itani, T., Moubarak, M., Aftimos, G., and Far\u00e8s, N. (2014). Hypothyroidism and its rapid correction alter cardiac remodeling. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109753"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ihj.2017.07.004","article-title":"Atrial fibrillation and hyperthyroidism: A literature review","volume":"69","author":"Reddy","year":"2017","journal-title":"Indian Heart J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/CIRCEP.113.000502","article-title":"Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats","volume":"6","author":"Zhang","year":"2013","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e7895","DOI":"10.1136\/bmj.e7895","article-title":"The spectrum of thyroid disease and risk of new onset atrial fibrillation: A large population cohort study","volume":"345","author":"Selmer","year":"2012","journal-title":"BMJ"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1161\/CIRCULATIONAHA.117.028753","article-title":"Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation","volume":"136","author":"Baumgartner","year":"2017","journal-title":"Circulation"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Singh, H., Shahid, M.Z., Harrison, S.L., Lane, D.A., Lip, G.Y.H., and Logantha, S.J.R.J. (2024). Subclinical thyroid dysfunction and the risk of incident atrial fibrillation: A systematic review and meta-analysis. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0296413"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e12829","DOI":"10.1111\/jpi.12829","article-title":"Melatonin improves cardiac remodeling and brain\u2013heart sympathetic hyperactivation aggravated by light disruption after myocardial infarction","volume":"73","author":"Jiao","year":"2022","journal-title":"J. Pineal Res."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Tu, Y., Song, E., Wang, Z., Ji, N., Zhu, L., Wang, K., Sun, H., Zhang, Y., Zhu, Q., and Liu, X. (2021). Melatonin attenuates oxidative stress and inflammation of M\u00fcller cells in diabetic retinopathy via activating the Sirt1 pathway. Biomed. Pharmacother., 137.","DOI":"10.1016\/j.biopha.2021.111274"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"D\u2019Angelo, G., Chimenz, R., Reiter, R.J., and Gitto, E. (2020). Use of melatonin in oxidative stress related neonatal diseases. Antioxidants, 9.","DOI":"10.3390\/antiox9060477"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Hohor, S., Mandanach, C., Maftei, A., Zugravu, C.A., and O\u021belea, M.R. (2023). Impaired Melatonin Secretion, Oxidative Stress and Metabolic Syndrome in Night Shift Work. Antioxidants, 12.","DOI":"10.3390\/antiox12040959"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e12851","DOI":"10.1111\/jpi.12851","article-title":"Melatonin increases susceptibility to atrial fibrillation in obesity via Akt signaling impairment in response to lipid overload","volume":"74","author":"Qin","year":"2023","journal-title":"J. Pineal Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.15420\/ecr.2023.18.PO8","article-title":"Evaluating the Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation following Coronary Artery Bypass Graft Surgery: A Randomised Controlled Trial","volume":"18","author":"Dastan","year":"2023","journal-title":"Eur. Cardiol. Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.2174\/1871530320666200728152307","article-title":"The Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation after Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial","volume":"21","author":"Barati","year":"2020","journal-title":"Endocr. Metab. Immune. Disord. Drug Targets"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5152\/eurasianjmed.2018.0010","article-title":"Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level","volume":"50","author":"Gunaydin","year":"2018","journal-title":"Eurasian J. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.mehy.2004.12.021","article-title":"Can chronic use of anti-inflammatory agents paradoxically promote chronic inflammation through compensatory host response?","volume":"65","author":"Doux","year":"2005","journal-title":"Med. Hypotheses"},{"key":"ref_111","first-page":"1450","article-title":"Long-term Use of Anti-inflammatory Drugs and Risk of Atrial Fibrillation","volume":"170","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/eurheartj\/ehr421","article-title":"Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib","volume":"33","author":"Back","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/anec.12097","article-title":"Celecoxib-Induced Change in Atrial Electrophysiologic Substrate in Arthritis Patients","volume":"19","author":"Pizzuto","year":"2014","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/qjmed\/hcz307","article-title":"Nonsteroidal anti-inflammatory drugs and incidence of atrial fibrillation: A meta-analysis","volume":"113","author":"Chokesuwattanaskul","year":"2020","journal-title":"QJM Int. J. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(00)00699-9","article-title":"Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2\u2013specific inhibitors","volume":"110","author":"Whelton","year":"2001","journal-title":"Am. J. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5049\/EBP.2008.6.1.35","article-title":"Renal Effects of Prostaglandins and Cyclooxygenase-2 Inhibitors","volume":"6","author":"Kim","year":"2008","journal-title":"Electrolyte Blood Press."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"26586","DOI":"10.18632\/oncotarget.25005","article-title":"Prostaglandins in the pathogenesis of kidney diseases","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e000763","DOI":"10.1161\/JAHA.113.000763","article-title":"Aspirin Use and Risk of Atrial Fibrillation in the Physicians\u2019 Health Study","volume":"3","author":"Ofman","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.cjca.2021.06.011","article-title":"Management of Atrial Fibrillation in 2021: An Updated Comparison of the Current CCS\/CHRS, ESC, and AHA\/ACC\/HRS Guidelines","volume":"37","author":"Cheung","year":"2021","journal-title":"Can. J. Cardiol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Romiti, G.F., Corica, B., Lip, G.Y.H., and Proietti, M. (2021). Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10112490"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Donniacuo, M., De Angelis, A., Rafaniello, C., Cianflone, E., Paolisso, P., Torella, D., Sibilio, G., Paolisso, G., Castaldo, G., and Urbanek, K. (2023). COVID-19 and atrial fibrillation: Intercepting lines. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1093053"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1590\/1516-3180.2022.0170.r1.01072022","article-title":"Effectiveness and safety of tocilizumab for COVID-19: A systematic review and meta-analysis of randomized clinical trials","volume":"141","author":"Almeida","year":"2023","journal-title":"Sao Paulo Med. J."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/S0735-1097(22)03081-9","article-title":"Effect of Tocilizumab on New Onset Atrial Fibrillation and Mortality in COVID-19 Patients: An Umbrella Review","volume":"79","author":"Patel","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/acr.22455","article-title":"Antiarrhythmic Potential of Anticytokine Therapy in Rheumatoid Arthritis: Tocilizumab Reduces Corrected QT Interval by Controlling Systemic Inflammation","volume":"67","author":"Lazzerini","year":"2015","journal-title":"Arthritis Care Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1099\/0022-1317-4-2-203","article-title":"Comparison of the Antiviral Activity In Vitro of Some Non-Steroidal Anti-Inflammatory Drugs","volume":"4","author":"Inglot","year":"1969","journal-title":"J. Gen. Virol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/0897190021997399","article-title":"The Rise and Fall of Hydroxychloroquine and Chloroquine in COVID-19","volume":"35","author":"Aljadeed","year":"2022","journal-title":"J. Pharm. Pract."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12471-020-01429-7","article-title":"Chloroquine-induced QTc prolongation in COVID-19 patients","volume":"28","author":"Abeln","year":"2020","journal-title":"Neth. Heart J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2003.11.003","article-title":"Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells","volume":"484","author":"Traebert","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Tob\u00f3n, C., Palacio, L.C., Chidipi, B., Slough, D.P., Tran, T., Tran, N., Reiser, M., Lin, Y.S., Herweg, B., and Sayad, D. (2019). The Antimalarial Chloroquine Reduces the Burden of Persistent Atrial Fibrillation. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.01392"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1161\/CIRCEP.111.966820","article-title":"Chloroquine Terminates Stretch-Induced Atrial Fibrillation More Effectively Than Flecainide in the Sheep Heart","volume":"5","author":"Martins","year":"2012","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_132","first-page":"142","article-title":"The role of rotors in atrial fibrillation","volume":"7","author":"Krummen","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e12476","DOI":"10.15252\/emmm.202012476","article-title":"Hydroxychloroquine in rheumatic autoimmune disorders and beyond","volume":"12","author":"Nirk","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/acr.24494","article-title":"Association of Hydroxychloroquine Use With Decreased Incident Atrial Fibrillation in Systemic Lupus Erythematosus","volume":"73","author":"Gupta","year":"2021","journal-title":"Arthritis Care Res."},{"key":"ref_136","first-page":"322","article-title":"Anti-cytokine Storm Activity of Fraxin, Quercetin, and their Combination on Lipopolysaccharide-Induced Cytokine Storm in Mice: Implications in COVID-19","volume":"49","author":"Shaker","year":"2024","journal-title":"Iran. J. Med. Sci."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8825387","article-title":"Quercetin: Its Main Pharmacological Activity and Potential Application in Clinical Medicine","volume":"2020","author":"Yang","year":"2020","journal-title":"Oxidative Med. Cell Longev."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/hc4601.099402","article-title":"Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs with Ventricular Tachypacing\u2014Induced Congestive Heart Failure","volume":"104","author":"Li","year":"2001","journal-title":"Circulation"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Tan, X., Xian, W., Li, X., Chen, Y., Geng, J., Wang, Q., Gao, Q., Tang, B., Wang, H., and Kang, P. (2022). Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-13911-w"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e008197","DOI":"10.1161\/CIRCEP.119.008197","article-title":"Canakinumab after Electrical Cardioversion in Patients with Persistent Atrial Fibrillation: A Pilot Randomized Trial","volume":"13","author":"Krisai","year":"2020","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjp.0706736","article-title":"How corticosteroids control inflammation: Quintiles Prize Lecture 2005","volume":"148","author":"Barnes","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1530\/JOE-16-0458","article-title":"Glucocorticoid receptor alters isovolumetric contraction and restrains cardiac fibrosis","volume":"232","author":"Richardson","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1292\/jvms.20-0401","article-title":"Long-term administration of prednisolone: Effects on the myocardial tissue of healthy beagle dogs","volume":"83","author":"Tanaka","year":"2021","journal-title":"J. Vet. Med. Sci."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Cruz-Topete, D., Oakley, R.H., and Cidlowski, J.A. (2020). Glucocorticoid Signaling and the Aging Heart. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00347"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Tesch, G.H., and Young, M.J. (2017). Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00313"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Ferreira, N.S., Bruder-Nascimento, T., Pereira, C.A., Zanotto, C.Z., Prado, D.S., Silva, J.F., Rassi, D.M., Foss-Freitas, M.C., Alves-Filho, J.C., and Carlos, D. (2019). NLRP3 inflammasome and mineralocorticoid receptors are associated with vascular dysfunction in type 2 diabetes mellitus. Cells, 8.","DOI":"10.3390\/cells8121595"},{"key":"ref_148","first-page":"20","article-title":"One hormone, two actions: Anti- AND pro-inflammatory effects of glucocorticoids","volume":"22","author":"Cidlowski","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jacc.2010.11.036","article-title":"Heat Shock Protein as a Mediator Between the Effects of Corticosteroids on Atrial Fibrillation Recurrence After Catheter Ablation","volume":"57","author":"Ng","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jsha.2016.03.005","article-title":"Use of short-term steroids in the prophylaxis of atrial fibrillation after cardiac surgery","volume":"29","author":"Anzeh","year":"2017","journal-title":"J. Saudi Heart Assoc."},{"key":"ref_151","first-page":"668","article-title":"3275Short term use of corticosteroids in the prophylaxis of atrial fibrillation after cardiac surgery and impact on the levels of acute phase proteins in this context","volume":"39","author":"Vilacosta","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Zhou, Z., Long, Y., He, X., and Li, Y. (2023). Effects of different doses of glucocorticoids on postoperative atrial fibrillation: A meta-analysis. BMC Cardiovasc. Disord., 23.","DOI":"10.1186\/s12872-022-03001-0"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2165\/11633140-000000000-00000","article-title":"Drug-induced atrial fibrillation","volume":"72","author":"Kaakeh","year":"2012","journal-title":"Drugs."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.bja.2017.10.025","article-title":"Steroids in cardiac surgery: A systematic review and meta-analysis","volume":"120","author":"Dvirnik","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"G\u0119gotek, A., and Skrzydlewska, E. (2022). Antioxidative and Anti-Inflammatory Activity of Ascorbic Acid. Antioxidants, 11.","DOI":"10.3390\/antiox11101993"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.4022\/jafib.1604","article-title":"Use of Oral Steroid and its Effects on Atrial Fibrillation Recurrence and Inflammatory Cytokines Post Ablation\u2014The Steroid AF Study","volume":"9","author":"Iskandar","year":"2017","journal-title":"J. Atr. Fibrillation"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3349\/ymj.2015.56.2.324","article-title":"Comparison of Two Different Doses of Single Bolus Steroid Injection to Prevent Atrial Fibrillation Recurrence after Radiofrequency Catheter Ablation","volume":"56","author":"Kim","year":"2015","journal-title":"Yonsei Med. J."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1631\/jzus.B1600529","article-title":"Effect of corticosteroids on atrial fibrillation after catheter ablation: A meta-analysis","volume":"19","author":"Jaiswal","year":"2018","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.accpm.2016.04.005","article-title":"The risk of atrial fibrillation after pneumonectomy is not impaired by preoperative administration of dexamethasone. A cohort study","volume":"36","author":"Rozencwajg","year":"2017","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archinte.166.9.1016","article-title":"Corticosteroids and the Risk of Atrial Fibrillation","volume":"166","author":"Heeringa","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"e014213","DOI":"10.1161\/JAHA.119.014213","article-title":"Vitamin C Intravenous Treatment in the Setting of Atrial Fibrillation Ablation: Results from the Randomized, Double-Blinded, Placebo-Controlled CITRIS-AF Pilot Study","volume":"9","author":"Trankle","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5603\/CJ.a2013.0154","article-title":"Effect of oral vitamin C on atrial fibrillation development after isolated coronary artery bypass grafting surgery: A prospective randomized clinical trial","volume":"21","author":"Dehghani","year":"2014","journal-title":"Cardiol. J."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"E415","DOI":"10.1532\/hsf.1938","article-title":"Preventive Use of Ascorbic Acid for Atrial Fibrillation After Coronary Artery Bypass Graft Surgery","volume":"21","author":"Mirmohammadsadeghi","year":"2018","journal-title":"Heart Surg. Forum"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jjcc.2016.01.010","article-title":"Perioperative ascorbic acid supplementation does not reduce the incidence of postoperative atrial fibrillation in on-pump coronary artery bypass graft patients","volume":"69","author":"Antonic","year":"2017","journal-title":"J. Cardiol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.15420\/ecr.2021.31","article-title":"Association between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis","volume":"16","author":"Condello","year":"2021","journal-title":"Eur. Cardiol. Rev."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jacc.2023.05.055","article-title":"Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease: JACC Review Topic of the Week","volume":"82","author":"Nelson","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2174\/1381612824666180116101823","article-title":"The Role of Colchicine in Pericardial Syndromes","volume":"24","author":"Lazaros","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/rheumatology\/kei140","article-title":"Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: A possible new outlook through microarray analysis","volume":"45","author":"Bergmann","year":"2006","journal-title":"Rheumatology"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.clinthera.2014.07.017","article-title":"Mechanism of action of colchicine in the treatment of gout","volume":"36","author":"Dalbeth","year":"2014","journal-title":"Clin. Ther."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1128\/iai.64.8.3379-3384.1996","article-title":"Microtubule-disrupting agents inhibit nitric oxide production in murine peritoneal macrophages stimulated with lipopolysaccharide or paclitaxel (taxol)","volume":"64","author":"Kirikae","year":"1996","journal-title":"Infect. Immun."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0022-3565(25)28113-7","article-title":"Histamine release from rat peritoneal mast cells: Inhibition by colchicine and potentiation by deuterium oxide","volume":"164","author":"Gillespie","year":"1968","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Zhan, Y., Yue, H., Zhao, X., Tang, J., and Wu, Z. (2023). Colchicine in atrial fibrillation: Are old trees in bloom?. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1260774"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s42255-021-00366-y","article-title":"Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation","volume":"3","author":"Weng","year":"2021","journal-title":"Nat. Metab."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00011-022-01540-y","article-title":"Colchicine for COVID-19: Targeting NLRP3 inflammasome to blunt hyperinflammation","volume":"71","author":"Bonaventura","year":"2022","journal-title":"Inflamm. Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mehy.2016.04.039","article-title":"Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation","volume":"92","author":"Demidowich","year":"2016","journal-title":"Med. Hypotheses"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_177","first-page":"1","article-title":"A meta-analysis of colchicine in prevention of atrial fibrillation following cardiothoracic surgery or cardiac intervention","volume":"17","author":"Zhao","year":"2022","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4103\/0253-7613.144905","article-title":"Colchicine in prevention of atrial fibrillation following cardiac surgery: Systematic review and meta-analysis","volume":"46","author":"Trivedi","year":"2014","journal-title":"Indian J. Pharmacol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/europace\/euad169","article-title":"Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: A meta-analysis of randomized controlled trials","volume":"25","author":"Agarwal","year":"2023","journal-title":"Europace"},{"key":"ref_180","first-page":"e35120","article-title":"The Effect of Colchicine on Atrial Fibrillation: A Systematic Review and Meta-Analysis","volume":"15","author":"Kommu","year":"2023","journal-title":"Cureus"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2022.1032116","article-title":"Colchicine for prevention of post-operative atrial fibrillation: Meta-analysis of randomized controlled trials","volume":"9","author":"Ge","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1381612824666180123110042","article-title":"Colchicine Pharmacokinetics and Mechanism of Action","volume":"24","author":"Angelidis","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40264-022-01265-1","article-title":"Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management","volume":"46","author":"Hansten","year":"2023","journal-title":"Drug Saf."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"e257186","DOI":"10.1136\/bcr-2023-257186","article-title":"CYP3A4\/P-glycoprotein inhibitors related colchicine toxicity mimicking septic shock","volume":"16","author":"Ngeyvijit","year":"2023","journal-title":"BMJ Case Rep."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.4238\/2013.January.24.2","article-title":"Lack of an effect of CYP3A4 and MDR1 gene polymorphisms on colchicine pharmacogenetics in the treatment of Familial Mediterranean fever","volume":"12","author":"Dogruer","year":"2013","journal-title":"Genet. Mol. Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1067\/mhj.2001.115297","article-title":"The Pravastatin Inflammation CRP Evaluation (PRINCE): Rationale and design","volume":"141","author":"Albert","year":"2001","journal-title":"Am. Heart J."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/10408363.2013.813013","article-title":"Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy","volume":"50","author":"Egom","year":"2013","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"154752","DOI":"10.1016\/j.cyto.2019.154752","article-title":"Statins influence biomarkers of low grade inflammation in apparently healthy people or patients with chronic diseases: A systematic review and meta-analysis of randomized clinical trials","volume":"123","author":"Milajerdi","year":"2019","journal-title":"Cytokine"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1172\/JCI0216421","article-title":"Isoprenoids as mediators of the biological effects of statins","volume":"110","author":"Liao","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/sj.bjp.0707114","article-title":"Statins induce S1P 1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins","volume":"150","author":"Igarashi","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/CS20130043","article-title":"NLRP3 inflammasome activation in coronary artery disease: Results from prospective and randomized study of treatment with atorvastatin or rosuvastatin","volume":"126","author":"Satoh","year":"2014","journal-title":"Clin. Sci."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s10020-019-0074-5","article-title":"LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-\u03b21-Smad axis in atrial fibrillation","volume":"25","author":"Cao","year":"2019","journal-title":"Mol. Med."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000506072","article-title":"Galectin-3 Induces Atrial Fibrosis by Activating the TGF-\u03b21\/Smad Pathway in Patients with Atrial Fibrillation","volume":"145","author":"Xiao","year":"2020","journal-title":"Cardiology"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijcard.2009.03.110","article-title":"Atrial fibrosis and atrial fibrillation: The role of the TGF-\u03b21 signaling pathway","volume":"143","author":"Gramley","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"e142548","DOI":"10.1172\/JCI142548","article-title":"miR-181b targets semaphorin 3A to mediate TGF-\u03b2\u2013induced endothelial-mesenchymal transition related to atrial fibrillation","volume":"132","author":"Lai","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/cvr\/cvy224","article-title":"Absence of natriuretic peptide clearance receptor attenuates TGF-\u03b21-induced selective atrial fibrosis and atrial fibrillation","volume":"115","author":"Rahmutula","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1034\/j.1600-0773.2003.930304.x","article-title":"Lovastatin Induces Relaxation and Inhibits L-Type Ca2+ Current in the Rat Basilar Artery","volume":"93","author":"Bergdahl","year":"2003","journal-title":"Pharmacol. Toxicol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s12012-021-09642-5","article-title":"Rosuvastatin Reduces L-Type Ca2+ Current and Alters Contractile Function in Cardiac Myocytes via Modulation of \u03b2-Adrenergic Receptor Signaling","volume":"21","author":"Ozturk","year":"2021","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/abbs\/gmw009","article-title":"Atorvastatin blocks increased l-type Ca2+ current and cell injury elicited by angiotensin II via inhibiting oxide stress","volume":"48","author":"Ma","year":"2016","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13395-021-00280-7","article-title":"The SarcoEndoplasmic Reticulum Calcium ATPase (SERCA) pump: A potential target for intervention in aging and skeletal muscle pathologies","volume":"11","author":"Xu","year":"2021","journal-title":"Skelet. Muscle"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.03.004","article-title":"Rosuvastatin suppresses atrial tachycardia-induced cellular remodeling via Akt\/Nrf2\/heme oxygenase-1 pathway","volume":"82","author":"Yeh","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Andelova, K., Bacova, B.S., Sykora, M., Hlivak, P., Barancik, M., and Tribulova, N. (2022). Mechanisms Underlying Antiarrhythmic Properties of Cardioprotective Agents Impacting Inflammation and Oxidative Stress. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031416"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bpj.2016.06.016","article-title":"Effect of Statins on the Nanomechanical Properties of Supported Lipid Bilayers","volume":"111","author":"Andersen","year":"2016","journal-title":"Biophys. J."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12551-014-0159-x","article-title":"Microdomain\u2013specific localization of functional ion channels in cardiomyocytes: An emerging concept of local regulation and remodelling","volume":"7","author":"Balycheva","year":"2015","journal-title":"Biophys. Rev."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2015.09.023","article-title":"Atorvastatin protects myocardium against ischemia\u2013reperfusion arrhythmia by increasing Connexin 43 expression: A rat model","volume":"768","author":"Bian","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2009.08.064","article-title":"Rac1-Induced Connective Tissue Growth Factor Regulates Connexin 43 and N-Cadherin Expression in Atrial Fibrillation","volume":"55","author":"Adam","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2015.11.016","article-title":"The activation of PI 3-kinase\/Akt pathway is involved in the acute effects of simvastatin against ischaemia and reperfusion-induced arrhythmias in anaesthetised dogs","volume":"769","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Cho, K.I., Cha, T.J., Lee, S.J., Shim, I.K., Zhang, Y.H., Heo, J.H., Kim, H.S., Kim, S.J., Kim, K.L., and Lee, J.W. (2014). Attenuation of Acetylcholine Activated Potassium Current (IKACh) by Simvastatin, Not Pravastatin in Mouse Atrial Cardiomyocyte: Possible Atrial Fibrillation Preventing Effects of Statin. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0106570"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"213","DOI":"10.14740\/cr1073","article-title":"Upstream Therapy for Atrial Fibrillation Prevention: The Role of Sacubitril\/Valsartan","volume":"11","author":"Paccone","year":"2020","journal-title":"Cardiol. Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"105418","DOI":"10.1016\/j.phrs.2021.105418","article-title":"Statin use and mortality in atrial fibrillation: A systematic review and meta-analysis of 100,287 patients","volume":"165","author":"Pastori","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"e032378","DOI":"10.1161\/JAHA.123.032378","article-title":"Statin Therapy Is Associated With a Lower Risk of Heart Failure in Patients With Atrial Fibrillation: A Population-Based Study","volume":"12","author":"Huang","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cjco.2022.12.012","article-title":"The Impact of Statins on Postdischarge Atrial Fibrillation After Cardiac Surgery: Secondary Analysis from a Randomized Trial","volume":"5","author":"Hibino","year":"2023","journal-title":"CJC Open"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"i300","DOI":"10.1093\/europace\/euad122.198","article-title":"Statin use improves the outcomes in patients with atrial fibrillation: A population-based study","volume":"25","author":"Huang","year":"2023","journal-title":"Europace"},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Ak\u015fit, E., Taylan, G., and K\u00fc\u00e7\u00fck, U. (2023). The importance of statin therapy in atrial fibrillation patients independent of CHADS-VASc score. Europace, 25.","DOI":"10.1093\/europace\/euad281"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"e028381","DOI":"10.1161\/JAHA.122.028381","article-title":"Statin Use and Stroke Rate in Older Adults With Atrial Fibrillation: A Population-Based Cohort Study","volume":"12","author":"Shweikialrefaee","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40256-022-00555-4","article-title":"Statins Reduce Bleeding Risk in Patients Taking Oral Anticoagulants for Nonvalvular Atrial Fibrillation: A Retrospective Registry Study","volume":"23","author":"Uchida","year":"2023","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Cholewski, M., Tomczykowa, M., and Tomczyk, M. (2018). A Comprehensive Review of Chemistry, Sources and Bioavailability of Omega-3 Fatty Acids. Nutrients, 10.","DOI":"10.3390\/nu10111662"},{"key":"ref_218","first-page":"E673","article-title":"Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association","volume":"140","author":"Wilson","year":"2019","journal-title":"Circulation"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11883-019-0762-1","article-title":"New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease","volume":"21","year":"2019","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jacc.2018.04.061","article-title":"Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management","volume":"72","author":"Ganda","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"101681","DOI":"10.1016\/j.beem.2022.101681","article-title":"Omega-3-fatty acids: Do they prevent cardiovascular disease?","volume":"37","author":"Mason","year":"2023","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Liu, Y.X., Yu, J.H., Sun, J.H., Ma, W.Q., Wang, J.J., and Sun, G.J. (2023). Effects of Omega-3 Fatty Acids Supplementation on Serum Lipid Profile and Blood Pressure in Patients with Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Foods, 12.","DOI":"10.3390\/foods12040725"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1017\/S0007114512001584","article-title":"Omega-3 fatty acids and blood pressure","volume":"107","author":"Cabo","year":"2012","journal-title":"Br. J. Nutr."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects","volume":"142","author":"Talukdar","year":"2010","journal-title":"Cell"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.32734\/idjpcr.v2i2.2666","article-title":"Evaluation of Antiinflammatory Activity of Marine Omega-3 in Rats","volume":"2","author":"Faizah","year":"2020","journal-title":"Indones. J. Pharm. Clin. Res."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s11010-020-03965-7","article-title":"Omega-3 polyunsaturated fatty acids: Anti-inflammatory and anti-hypertriglyceridemia mechanisms in cardiovascular disease","volume":"476","author":"Shibabaw","year":"2021","journal-title":"Mol. Cell Biochem."},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Simonetto, M., Infante, M., Sacco, R.L., Rundek, T., and Della-Morte, D. (2019). A Novel Anti-Inflammatory Role of Omega-3 PUFAs in Prevention and Treatment of Atherosclerosis and Vascular Cognitive Impairment and Dementia. Nutrients, 11.","DOI":"10.3390\/nu11102279"},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Oppedisano, F., Macr\u00ec, R., Gliozzi, M., Musolino, V., Carresi, C., Maiuolo, J., Bosco, F., Nucera, S., Caterina Zito, M., and Guarnieri, L. (2020). The Anti-Inflammatory and Antioxidant Properties of n-3 PUFAs: Their Role in Cardiovascular Protection. Biomedicines, 8.","DOI":"10.3390\/biomedicines8090306"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s10741-023-10327-0","article-title":"Does omega-3 supplementation improve the inflammatory profile of patients with heart failure? a systematic review and meta-analysis","volume":"28","author":"Prokopidis","year":"2023","journal-title":"Heart Fail. Rev."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","article-title":"Omega-3 Fatty Acids Prevent Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome Activation","volume":"38","author":"Yan","year":"2013","journal-title":"Immunity"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jjcc.2015.08.002","article-title":"Cardioprotective mechanism of omega-3 polyunsaturated fatty acids","volume":"67","author":"Endo","year":"2016","journal-title":"J. Cardiol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3904\/kjim.2022.266","article-title":"Omega-3 fatty acids and atrial fibrillation","volume":"38","author":"Huh","year":"2023","journal-title":"Korean J. Intern. Med."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk","volume":"324","author":"Nicholls","year":"2020","journal-title":"JAMA"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"e0977","DOI":"10.1097\/CCE.0000000000000977","article-title":"Omega-3 Fatty Acids as Antiarrhythmic Drugs: Upstream Target Modulators Affecting Acute and Long-Term Pathological Alterations in Cardiac Structure and Function","volume":"5","author":"Driscoll","year":"2023","journal-title":"Crit. Care Explor."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/CIRCULATIONAHA.121.058596","article-title":"Fishing for Links Between Omega-3 Fatty Acids and Atrial Fibrillation","volume":"145","author":"Fatkin","year":"2022","journal-title":"Circulation"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"286","DOI":"10.21873\/invivo.13078","article-title":"Vitamin D3 Supplementation Promotes Regulatory T-Cells to Maintain Immune Homeostasis After Surgery for Early Stages of Colorectal Cancer","volume":"37","author":"Srichomchey","year":"2023","journal-title":"Vivo"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"38751","DOI":"10.1074\/jbc.C110.185777","article-title":"Vitamin D Suppresses Th17 Cytokine Production by Inducing C\/EBP Homologous Protein (CHOP) Expression","volume":"285","author":"Chang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"8975396","DOI":"10.1155\/2022\/8975396","article-title":"Association between Vitamin D Deficiency and Levels of Renin and Angiotensin in Essential Hypertension","volume":"2022","author":"Han","year":"2022","journal-title":"Int. J. Clin. Pract."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4196\/kjpp.2013.17.5.385","article-title":"Effects of Vitamin D on Blood Pressure and Endothelial Function","volume":"17","author":"Min","year":"2013","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/TP.0b013e3181c6910f","article-title":"Potential Nonclassical Effects of Vitamin D in Transplant Recipients","volume":"89","author":"Courbebaisse","year":"2010","journal-title":"Transplantation"},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Rao, Z., Chen, X., Wu, J., Xiao, M., Zhang, J., Wang, B., Fang, L., Zhang, H., Wang, X., and Yang, S. (2019). Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02783"},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Verway, M., Bouttier, M., Wang, T.T., Carrier, M., Calderon, M., An, B.S., Devemy, E., McIntosh, F., Divangahi, M., and Behr, M.A. (2013). Vitamin D Induces Interleukin-1\u03b2 Expression: Paracrine Macrophage Epithelial Signaling Controls M. tuberculosis Infection. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003407"},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Abdelrahman, B.A., Hammam, O.A., El-Khatib, A.S., and Attia, Y.M. (2023). The role of vitamin D3 in modulating the interplay between NLRP3 inflammasome and autophagy in NASH. Biochem. Biophys. Res. Commun., 688.","DOI":"10.1016\/j.bbrc.2023.149122"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/JLB.3MA0320-406RR","article-title":"1,25(OH)2D3 alleviates DSS-induced ulcerative colitis via inhibiting NLRP3 inflammasome activation","volume":"108","author":"Cao","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Ding, X., Lai, J., Zhang, H., and Guo, Z. (2023). Vitamin D, vitamin D supplementation and atrial fibrillation risk in the general population: Updated systematic review and meta-analysis of prospective studies. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1246359"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ahj.2023.05.024","article-title":"The effect of vitamin D3 supplementation on atrial fibrillation in generally healthy men and women: The Finnish Vitamin D Trial","volume":"264","author":"Virtanen","year":"2023","journal-title":"Am. Heart J."},{"key":"ref_249","first-page":"e36496","article-title":"The Role of Vitamin D Supplementation Before Coronary Artery Bypass Grafting in Preventing Postoperative Atrial Fibrillation in Patients With Vitamin D Deficiency or Insufficiency: A Systematic Review and Meta-Analysis","volume":"15","author":"Ansari","year":"2023","journal-title":"Cureus"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"110626","DOI":"10.1016\/j.diabres.2023.110626","article-title":"Association between antidiabetic drugs and the incidence of atrial fibrillation in patients with type 2 diabetes: A nationwide cohort study in South Korea","volume":"198","author":"Kim","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1042\/BST20130032","article-title":"Immune responses of macrophages and dendritic cells regulated by mTOR signalling","volume":"41","author":"Katholnig","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Sch\u00f6nberger, E., Mihaljevi\u0107, V., Steiner, K., \u0160ari\u0107, S., Kurevija, T., Majnari\u0107, L.T., Bili\u0107 \u0106ur\u010di\u0107, I., and Canecki-Var\u017ei\u0107, S. (2023). Immunomodulatory Effects of SGLT2 Inhibitors\u2014Targeting Inflammation and Oxidative Stress in Aging. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20176671"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"102934","DOI":"10.1016\/j.dsx.2023.102934","article-title":"Antifibrotic effects of sodium-glucose cotransporter-2 inhibitors: A comprehensive review","volume":"18","author":"Shakour","year":"2024","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"102524","DOI":"10.1016\/j.cpcardiol.2024.102524","article-title":"Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement","volume":"49","author":"Alsereidi","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12933-014-0123-x","article-title":"Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: A population-based dynamic cohort and in vitro studies","volume":"13","author":"Chang","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Lorenzo-Almor\u00f3s, A., Casado Cerrada, J., \u00c1lvarez-Sala Walther, L.A., M\u00e9ndez Bail\u00f3n, M., and Lorenzo Gonz\u00e1lez, \u00d3. (2023). Atrial Fibrillation and Diabetes Mellitus: Dangerous Liaisons or Innocent Bystanders?. J. Clin. Med., 12.","DOI":"10.3390\/jcm12082868"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4239\/wjd.v14.i5.512","article-title":"Diabetes mellitus and atrial fibrillation-from pathophysiology to treatment","volume":"14","author":"Leopoulou","year":"2023","journal-title":"World J. Diabetes."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","article-title":"Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus","volume":"141","author":"Zelniker","year":"2020","journal-title":"Circulation"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12933-020-01105-5","article-title":"SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: A systematic review with meta-analysis of 16 randomized controlled trials","volume":"19","author":"Li","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12933-021-01293-8","article-title":"Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: A systematic review and meta-analysis","volume":"20","author":"Li","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_261","doi-asserted-by":"crossref","unstructured":"Di, Z., Ze-Mu, W., and Lian-Sheng, W. (2015). Prevention of atrial fibrillation with renin-angiotensin system inhibitors on essential hypertensive patients: A meta-analysis of randomized controlled trials. J. Biomed. Res., 29.","DOI":"10.7555\/JBR.29.20140149"},{"key":"ref_262","doi-asserted-by":"crossref","unstructured":"Filippatos, G., Farmakis, D., Butler, J., Zannad, F., Ferreira, J.P., Ofstad, A.P., Iwata, T., Brueckmann, M., Pocock, S.J., and Packer, M. (2023). Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation. Eur. J. Heart Fail., 25.","DOI":"10.1002\/ejhf.2861"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"e030552","DOI":"10.1161\/JAHA.123.030552","article-title":"Differing Efficacy of Dapagliflozin Versus Empagliflozin on the Risk of Incident Atrial Fibrillation in Patients With Type 2 Diabetes: A Real-World Observation Using a Nationwide, Population-Based Cohort","volume":"13","author":"Lim","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10741-022-10281-3","article-title":"Association between sodium-glucose cotransporter-2 inhibitors and incident atrial fibrillation\/atrial flutter in heart failure patients with reduced ejection fraction: A meta-analysis of randomized controlled trials","volume":"28","author":"Sfairopoulos","year":"2023","journal-title":"Heart Fail. Rev."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2337\/dc22-0714","article-title":"Sodium\u2013Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study","volume":"46","author":"Wintzell","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1093\/eurheartj\/ehac544.2948","article-title":"Empagliflozin inhibits increased Na influx in HFpEF cardiomyocytes and reduces arrhythmic activity in human atrial trabeculae","volume":"43","author":"Trum","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjmed.2018.02.026","article-title":"Thiazolidinediones and Risk of Atrial Fibrillation Among Patients with Diabetes and Coronary Disease","volume":"131","author":"Pallisgaard","year":"2018","journal-title":"Am. J. Med."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.hrthm.2021.03.007","article-title":"Comparison of the effect of glucose-lowering agents on the risk of atrial fibrillation: A network meta-analysis","volume":"18","author":"Shi","year":"2021","journal-title":"Heart Rhythm."},{"key":"ref_269","doi-asserted-by":"crossref","unstructured":"Liou, Y.S., Yang, F.Y., Chen, H.Y., and Jong, G.P. (2018). Antihyperglycemic drugs use and new-onset atrial fibrillation: A population-based nested case control study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197245"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s42444-021-00057-5","article-title":"Pathophysiological aspects of insulin resistance in Atrial Fibrillation: Novel therapeutic approaches","volume":"23","author":"Rafaqat","year":"2022","journal-title":"Int. J. Arrhythmia"},{"key":"ref_271","doi-asserted-by":"crossref","unstructured":"L\u0103c\u0103tu\u0219u, C.M., Grigorescu, E.D., St\u0103tescu, C., Sasc\u0103u, R.A., Onofriescu, A., and Mihai, B.M. (2019). Association of Antihyperglycemic Therapy with Risk of Atrial Fibrillation and Stroke in Diabetic Patients. Medicina, 55.","DOI":"10.3390\/medicina55090592"},{"key":"ref_272","first-page":"140","article-title":"Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: A nationwide cohort study","volume":"3","author":"Pallisgaard","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"100917","DOI":"10.1016\/j.jpha.2023.12.007","article-title":"GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation","volume":"14","author":"Zhong","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"e005945","DOI":"10.1161\/JAHA.117.005945","article-title":"Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits","volume":"6","author":"Zhang","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.hrthm.2015.03.010","article-title":"Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits","volume":"12","author":"Yamamoto","year":"2015","journal-title":"Heart Rhythm."},{"key":"ref_276","first-page":"e1","article-title":"Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the management of atrial fibrillation","volume":"14","author":"Anis","year":"2009","journal-title":"Exp. Clin. Cardiol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehi668","article-title":"Role of angiotensin system and effects of its inhibition in atrial fibrillation: Clinical and experimental evidence","volume":"27","author":"Ehrlich","year":"2006","journal-title":"Eur. Heart J."},{"key":"ref_278","doi-asserted-by":"crossref","unstructured":"Ekholm, M., and Kahan, T. (2021). The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.640185"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/CRD.0b013e3181b18e03","article-title":"Essential Hypertension","volume":"17","author":"Androulakis","year":"2009","journal-title":"Cardiol. Rev."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1046\/j.1523-1755.2002.00365.x","article-title":"Angiotensin II activates nuclear transcription factor-\u03baB through AT1 and AT2 receptors11See Editorial by Luft, p. 2272","volume":"61","author":"Wolf","year":"2002","journal-title":"Kidney Int."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1007\/s10753-022-01707-z","article-title":"Angiotensin II Triggers NLRP3 Inflammasome Activation by a Ca2+ Signaling-Dependent Pathway in Rat Cardiac Fibroblast Ang-II by a Ca2+-Dependent Mechanism Triggers NLRP3 Inflammasome in CF","volume":"45","author":"Boza","year":"2022","journal-title":"Inflammation"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1527-5299.2000.80159.x","article-title":"Ventricular Remodeling and the Renin Angiotensin Aldosterone System","volume":"6","author":"Patten","year":"2000","journal-title":"Congest. Heart Fail."},{"key":"ref_283","doi-asserted-by":"crossref","unstructured":"Adamcova, M., Kawano, I., and Simko, F. (2021). The Impact of microRNAs in Renin\u2013Angiotensin-System-Induced Cardiac Remodelling. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094762"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1470320308097416","article-title":"Role of renin in heart failure and therapeutic potential of direct renin inhibition","volume":"9","author":"Krum","year":"2008","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2010.01.043","article-title":"Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition","volume":"55","author":"Schneider","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/FJC.0b013e3182a094a1","article-title":"Renin\u2013Angiotensin System Inhibitors Prevent the Recurrence of Atrial Fibrillation","volume":"62","author":"Han","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_288","first-page":"689360","article-title":"The renin-angiotensin-aldosterone system in vascular inflammation and remodeling","volume":"2014","author":"Pacurari","year":"2014","journal-title":"Int. J. Inflam."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"16633","DOI":"10.1074\/jbc.M109.008748","article-title":"Aldosterone Stimulates Elastogenesis in Cardiac Fibroblasts via Mineralocorticoid Receptor-independent Action Involving the Consecutive Activation of G\u03b113, c-Src, the Insulin-like Growth Factor-I Receptor, and Phosphatidylinositol 3-Kinase\/Akt","volume":"284","author":"Bunda","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_290","doi-asserted-by":"crossref","unstructured":"Guitart-Mampel, M., Urquiza, P., Borges, J.I., Lymperopoulos, A., and Solesio, M.E. (2021). Impact of aldosterone on the failing myocardium: Insights from mitochondria and adrenergic receptors signaling and function. Cells, 10.","DOI":"10.3390\/cells10061552"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/jir.2017.0067","article-title":"Eplerenone Modulates Interleukin-33\/sST2 Signaling and IL-1\u03b2 in Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction","volume":"38","author":"Chen","year":"2018","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchf.2014.07.015","article-title":"Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33\/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction","volume":"3","author":"Lax","year":"2015","journal-title":"JACC Heart Fail."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1159\/000355736","article-title":"Eplerenone-mediated aldosterone blockade prevents renal fibrosis by reducing renal inflammation, interstitial cell proliferation and oxidative stress","volume":"37","author":"Chen","year":"2013","journal-title":"Kidney Blood Press. Res."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"e013267","DOI":"10.1161\/JAHA.119.013267","article-title":"Effects of Mineralocorticoid Receptor Antagonists on Atrial Fibrillation Occurrence: A Systematic Review, Meta-Analysis, and Meta-Regression to Identify Modifying Factors","volume":"8","author":"Alexandre","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijcard.2016.12.029","article-title":"Aldosterone Pathway Blockade to Prevent Atrial Fibrillation: A Systematic Review and Meta-Analysis","volume":"231","author":"Neefs","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.amjcard.2023.04.038","article-title":"A Systematic Review and Meta-Analysis on Effectiveness of Mineralocorticoid Receptor Antagonists in Reducing the Risk of Atrial Fibrillation","volume":"199","author":"Fatima","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"102742","DOI":"10.1016\/j.cpcardiol.2024.102742","article-title":"Effects of mineralocorticoid receptor antagonists on new-onset or recurrent atrial fibrillation: A Bayesian and frequentist network meta-analysis of randomized trials","volume":"49","author":"Karakasis","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/eurheartj\/ehad811","article-title":"Mineralocorticoid receptor antagonists and atrial fibrillation: A meta-analysis of clinical trials","volume":"45","author":"Oraii","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s00392-023-02349-3","article-title":"Incidence and progression of atrial fibrillation in patients with and without heart failure using mineralocorticoid receptor antagonists: A meta-analysis","volume":"113","author":"Nogueira","year":"2024","journal-title":"Clin. Res. Cardiol."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.jacc.2017.10.014","article-title":"Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling","volume":"70","author":"Takemoto","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/eme07040","article-title":"Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: The IMPRESS-AF RCT","volume":"7","author":"Shantsila","year":"2020","journal-title":"Effic. Mech. Eval."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"e0422","DOI":"10.24207\/jca.v35i1.3470","article-title":"Major Interleukins: Role in the Pathogenesis of Atrial Fibrillation","volume":"35","author":"Rafaqat","year":"2022","journal-title":"J. Card. Arrhythm."},{"key":"ref_303","doi-asserted-by":"crossref","unstructured":"Tanaka, T., Narazaki, M., and Kishimoto, T. (2014). Il-6 in inflammation, Immunity, And disease. Cold Spring Harb. Perspect. Biol., 6.","DOI":"10.1101\/cshperspect.a016295"},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.hrthm.2023.08.026","article-title":"Selective blockade of interleukin 6 trans-signaling depresses atrial fibrillation","volume":"20","author":"Li","year":"2023","journal-title":"Heart Rhythm."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-022-02376-4","article-title":"Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2\/STAT3\/Sox4\/NLRP3 signaling pathway","volume":"41","author":"Xiao","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_306","doi-asserted-by":"crossref","unstructured":"Jiang, H., Yang, J., Li, T., Wang, X., Fan, Z., Ye, Q., and Du, Y. (2024). JAK\/STAT3 signaling in cardiac fibrosis: A promising therapeutic target. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1336102"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.repc.2020.07.009","article-title":"Increased serum interleukin-6 level as a predictive biomarker for atrial fibrillation: A systematic review and meta-analysis","volume":"39","author":"Zhou","year":"2020","journal-title":"Rev. Port. De Cardiol."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13019-024-02813-9","article-title":"Left atrial volume index and interleukin-6 as predictors for postoperative atrial fibrillation","volume":"19","author":"Tao","year":"2024","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_309","doi-asserted-by":"crossref","unstructured":"Kornej, J., Dinov, B., Blann, A.D., Rolf, S., Arya, A., Schmidl, J., Husser, D., Hindricks, G., Bollmann, A., and Lip, G.Y. (2014). Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von willebrand factor and IL-6 in the peripheral and cardiac circulation. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0111760"},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00508-016-1002-0","article-title":"Radiofrequency catheter ablation versus balloon cryoablation of atrial fibrillation: Markers of myocardial damage, inflammation, and thrombogenesis","volume":"128","author":"Pernat","year":"2016","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_311","doi-asserted-by":"crossref","unstructured":"Vercek, G., Jug, B., Novakovic, M., Antonic, M., Djordjevic, A., and Ksela, J. (2024). Conventional and Novel Inflammatory Biomarkers in Chronic Heart Failure Patients with Atrial Fibrillation. Medicina, 60.","DOI":"10.3390\/medicina60081238"},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/joa3.13114","article-title":"Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients","volume":"40","author":"Accioli","year":"2024","journal-title":"J. Arrhythm."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s11886-023-01990-8","article-title":"The Brain\u2013Heart Axis: Neuroinflammatory Interactions in Cardiovascular Disease","volume":"25","author":"Hu","year":"2023","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_314","unstructured":"(2024, December 13). EUCTR2020-004853-59-GR. ZEUS\u2014A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People with Cardiovascular Disease, Chronic Kidney Disease and Inflammation. Available online: https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2020-004853-59-GR."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jjcc.2023.05.006","article-title":"Efficacy and safety of interleukin-6 inhibition with ziltivekimab in patients at high risk of atherosclerotic events in Japan (RESCUE-2): A randomized, double-blind, placebo-controlled, phase 2 trial","volume":"82","author":"Wada","year":"2023","journal-title":"J. Cardiol."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): A double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"ref_317","doi-asserted-by":"crossref","unstructured":"Buonacera, A., Stancanelli, B., Colaci, M., and Malatino, L. (2022). Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073636"},{"key":"ref_318","first-page":"1","article-title":"Neutrophil-to-lymphocyte ratio and mortality in the United States general population","volume":"11","author":"Song","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jacbts.2022.10.001","article-title":"Macrophage-Specific NLRC5 Protects From Cardiac Remodeling Through Interaction With HSPA8","volume":"8","author":"Yu","year":"2023","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nri3339","article-title":"NLRC5: A key regulator of MHC class I-dependent immune responses","volume":"12","author":"Kobayashi","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_321","first-page":"103","article-title":"Fluvastatin therapy could not decrease progression of paroxysmal atrial fibrillation in non-valvular disease patients","volume":"18","author":"Tan","year":"2017","journal-title":"Anatol J. Cardiol."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1111\/bcp.15711","article-title":"Concomitant use of statins and sodium-glucose co-transporter 2 inhibitors and the risk of myotoxicity reporting: A disproportionality analysis","volume":"89","author":"Gravel","year":"2023","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_323","doi-asserted-by":"crossref","unstructured":"Li, C.X., Liang, S., Gao, L., and Liu, H. (2021). Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0244689"},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1111\/bph.16470","article-title":"Targeting the NLRP3 inflammasome signalling for the management of atrial fibrillation","volume":"181","author":"Niskala","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.hrthm.2014.02.002","article-title":"Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: Mid-term efficacy and effect on quality of life","volume":"11","author":"Deftereos","year":"2014","journal-title":"Heart Rhythm."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/3\/882\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:38:03Z","timestamp":1759919883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/3\/882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":325,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["jcm14030882"],"URL":"https:\/\/doi.org\/10.3390\/jcm14030882","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]}}}